Vetter celebrated the start of construction on its new clinical manufacturing site in the Chicago area with an official groundbreaking ceremony. The state-of-the-art facility, which is being built in Des Plaines, Illinois, is expected to be ready for media fill by the end of 2029. This $285 million investment will strengthen Vetter’s position as a leading global partner for aseptic manufacturing in early clinical development.
The new site provides additional capacity for small-batch production of novel active ingredients and includes space for warehouses, laboratories, and administrative offices. The approximately 860,000 square feet site has the capacity to accommodate future expansion, contingent on global demand and additional strategic investments.
This project marks another milestone in our international growth strategy. It underscores our commitment to quality and innovation, as well as our responsibility to our customers, partners, and patients around the world.
Senator h.c. Udo J. Vetter, Chairman of the Advisory Board
With its new location, Vetter is strengthening its presence in the North American market and supplementing its existing clinical network in Skokie, Illinois and Rankweil, Austria.
